Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Pemphigus Vulgaris vs Bullous Pemphigoid

Pemphigus Vulgaris vs Bullous Pemphigoid

USMLE Step 1 trap: Confuses the split level in pemphigus vulgaris (intraepidermal) with bullous pemphigoid (subepidermal). Pemphigus vulgaris causes intraepidermal (suprabasal) blistering via anti-desmoglein antibodies, while bullous pemphigoid causes subepidermal blistering via anti-hemidesmosome (BP180/BP230) antibodies.

Pemphigus vulgaris (PV) and bullous pemphigoid (BP) are the two autoimmune blistering diseases you absolutely must distinguish for USMLE Step 1. Both involve IgG autoantibodies attacking skin proteins, but they target different structures at different depths — and that single difference explains everything downstream: blister morphology, mucosal involvement, DIF pattern, and prognosis. The exam tests this concept from multiple angles: pure recall (which antibody goes with which disease), pathophysiology application (why are BP bullae tense while PV bullae are flaccid?), and clinical passage interpretation (a vignette describing oral ulcers preceding skin lesions, or an elderly patient with tense non-rupturing blisters). Getting these diseases confused on Step 1 is extremely common because students memorize isolated facts without anchoring them to the underlying mechanism.

The core anchor is split level. In PV, anti-desmoglein 3 (and sometimes anti-desmoglein 1) antibodies destroy keratinocyte-to-keratinocyte adhesion within the epidermis, producing a suprabasal split — the blister roof is just a few cell layers thick, so it ruptures with minimal pressure (Nikolsky sign positive). In BP, anti-BP180 and anti-BP230 antibodies destroy hemidesmosomes, which anchor the epidermis to the basement membrane. The split is subepidermal, so the entire epidermis forms the blister roof — thick, tense, and resistant to rupture (Nikolsky sign negative). This is the mechanical explanation the exam expects you to know.

What makes this topic tricky is that students frequently flip the DIF patterns, assume mucosal disease belongs to BP (it doesn't — that's PV's hallmark), or conflate intraepidermal and subepidermal as interchangeable vocabulary. The misconceptions in this topic are predictable and the exam exploits all of them. Lock in the mechanism first, then the details fall into place.

From real student decks
89%have cards covering this topic
73%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Both pemphigus vulgaris and bullous pemphigoid cause intraepidermal blistering.
Right: Pemphigus vulgaris causes intraepidermal (suprabasal) blistering via anti-desmoglein antibodies, while bullous pemphigoid causes subepidermal blistering via anti-hemidesmosome (BP180/BP230) antibodies.
PV antibodies target desmoglein, which is a desmosomal protein holding keratinocytes together within the epidermis — so when it's destroyed, the split happens inside the epidermis (suprabasally). BP antibodies target hemidesmosomes, which anchor the bottom of the epidermis to the basement membrane — so when those fail, the entire epidermis peels off as a sheet, creating a subepidermal split. These are anatomically distinct structures, and the split level predicts everything else about each disease.
Common mistake
Wrong: Bullous pemphigoid produces fragile, easily ruptured bullae like pemphigus vulgaris.
Right: Bullous pemphigoid produces tense, thick-roofed bullae that resist rupture because the split is subepidermal; pemphigus vulgaris bullae are flaccid and rupture easily.
Blister fragility is directly determined by how much tissue forms the blister roof. In PV, the split is suprabasal — only a thin layer of cells sits above the split, making an extremely fragile roof that ruptures with lateral pressure (Nikolsky positive). In BP, the split is subepidermal — the entire epidermis is intact above the split, creating a thick, durable roof that resists rupture (Nikolsky negative). Tense bullae = BP = subepidermal; flaccid bullae = PV = intraepidermal.
Common mistake
Wrong: Both pemphigus vulgaris and bullous pemphigoid show linear IgG deposition on direct immunofluorescence.
Right: Pemphigus vulgaris shows intercellular 'fishnet/tombstone' IgG pattern on DIF, while bullous pemphigoid shows linear IgG and C3 at the basement membrane zone.
The DIF pattern directly reflects where the antibody binds. In PV, anti-desmoglein IgG coats the surface of individual keratinocytes throughout the epidermis, producing an intercellular 'fishnet' or 'tombstone' pattern — the outlines of each cell light up. In BP, IgG and C3 deposit at the dermal-epidermal junction (basement membrane zone), producing a smooth, linear band. If you remember where the antigen lives anatomically, the DIF pattern is not something you need to memorize separately.
Common mistake
Wrong: Bullous pemphigoid commonly involves mucous membranes like pemphigus vulgaris.
Right: Mucosal involvement is a hallmark of pemphigus vulgaris (often the presenting feature); bullous pemphigoid rarely involves mucous membranes.
Mucosal involvement in PV is mechanistically explained: desmoglein 3 is highly expressed in the oral mucosa, so anti-desmoglein 3 antibodies frequently destroy mucosal epithelium — oral ulcers are often the first symptom and a classic exam clue. BP targets hemidesmosomes at the dermal-epidermal junction of skin, and mucous membranes are largely spared. A vignette with painful oral erosions preceding skin blisters is pointing you to PV, not BP.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. For pemphigus vulgaris specifically: identify the target antigen (anti-desmoglein 3 ± 1), the level of the split (intraepidermal, suprabasal), the blister character (flaccid, Nikolsky positive), and the DIF pattern (intercellular 'fishnet' or 'tombstone' IgG deposition throughout the epidermis).
  2. For bullous pemphigoid specifically: identify the target antigens (anti-BP180/collagen XVII and anti-BP230), the level of the split (subepidermal), the blister character (tense, thick-roofed, Nikolsky negative), and the DIF pattern (linear IgG and C3 along the basement membrane zone).
  3. Apply the mechanism of each disease to explain clinical features — why PV bullae rupture easily (thin intraepidermal roof), why BP bullae resist rupture (full epidermis as roof), why PV causes mucosal ulcers (desmoglein 3 is highly expressed in mucosa), and why BP typically spares mucous membranes.
  4. Distinguish management: both conditions are treated with systemic corticosteroids as first-line; PV additionally uses steroid-sparing agents like rituximab (anti-CD20) or azathioprine due to its more severe, potentially life-threatening course, while BP has a generally better prognosis and responds well to topical or systemic steroids.

Can you avoid these mistakes?

A 55-year-old man presents with painful oral ulcers for 2 months followed by flaccid skin blisters that rupture when rubbed laterally. DIF shows IgG deposited in a 'fishnet' pattern throughout the epidermis. What is the target antigen, and at what level does the blister form?
An 80-year-old woman presents with large, tense blisters on her trunk and thighs that do not rupture with firm pressure. She has no oral lesions. DIF shows linear IgG and C3 at the basement membrane zone. What structures are targeted by the pathogenic antibodies, and why are the bullae tense rather than flaccid?
You are given two DIF images: one shows a smooth linear band of IgG at the dermal-epidermal junction; the other shows an intercellular 'tombstone' pattern. Without any clinical information, which image goes with pemphigus vulgaris and which goes with bullous pemphigoid — and what is the mechanism behind each pattern?
A patient with newly diagnosed pemphigus vulgaris is started on systemic corticosteroids. The dermatologist also plans to add a steroid-sparing agent. What class of drug is rituximab, and why is aggressive immunosuppression more critical in PV than in bullous pemphigoid?

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →